Description
Tresiba FlexTouch Pens (100 units/mL) are pre-filled disposable pens containing 300 units of insulin. Tresiba is classified as an ultra-long-acting basal insulin, specifically insulin degludec. It is prescribed to manage diabetes mellitus in adults, adolescents, and children aged one year and older. Tresiba aids in lowering blood sugar levels and is intended for once-daily administration.
When deviations from your regular dosing schedule occur, you have flexibility in adjusting the dosing time due to Tresiba’s prolonged blood sugar-lowering effect. Tresiba can be combined with rapid-acting insulin for meals. For type 2 diabetes mellitus, Tresiba can be used alongside oral diabetes medications or other injectable antidiabetic treatments aside from insulin.
Insulin degludec serves as a substitute for the body’s natural insulin production. Its extended duration of action, similar to insulin detemir, provides a consistent low release throughout the day. This aids in transporting blood glucose into cells for energy utilization. Insulin degludec can be used alongside other diabetes medications, including shorter-acting insulin products.
Tresiba FlexTouch Pens, available in 200 units/mL as well, remain effective for up to eight weeks after being opened.
Reviews
There are no reviews yet.